Director, US Strategic Pricing, Pipeline

Key Responsibilities

• Develop and lead life cycle list and net price recommendations for pipeline portfolio and indication sequencing pricing strategies.
• Effectively partner with internal stakeholders to develop relationships to drive price strategy access including Global Market Access, Pricing, and Development, US Market Access Marketing, Field Key Account teams.
• Monitor, assess and recommend pricing adjustments to support life cycle management efforts consistent with pipeline indication expansion opportunities.
• Develop contract strategies and structures in close collaboration with USMA, brand and legal partners.
• Ensure compliance with all applicable laws, regulations, and company policies related to pricing and contracting.

Required Skills, Experience and Education

• Bachelor’s degree.
• Minimum of 8 years of pharmaceutical market access experience.
• 2+ years of Oncology product experience.
• 6+ years pricing, and payer/provider contracting experience to support mandated and discretionary price strategies.
• Extensive experience and demonstrated success in customer segment contract strategy, market knowledge, and pricing policies to support products and/or portfolio.
• Strong understanding relationship within IRA policy guidelines and CMS price demonstrations.
• Experience with day-to-day management of vendor partners.
• Strong knowledge of trends, issues and policies influencing drug pricing and oncology market.
• Ability to communicate effectively, both orally and in writing.
• Ability to effectively deliver strategy and price recommendations and presentations to a variety of audience types across all levels of the organization with impact.
• Embrace cross-functional collaboration with internal and external customers; possesses interpersonal skills to develop and maintain cooperative working and business relationships.
• Ability to effectively resolve conflicts and multi-department alignment to delivery commercial goals and objectives.

Preferred Skills

• Experience with oral oncology therapies and targeted treatments for RAS-mutated cancers.
• Advanced degree (MBA, MPH, or similar).